The EMCDDA Programming Document for the period 2018–20 covers the final year of implementation of the EMCDDA Strategy 2016–18 and coincides with the completion of the first Roadmap established under the new EMCDDA Strategy 2025. Among the highlights for this period are: the in-depth triennial assessment of the implementation of the key epidemiological indicators in the Member States; the scaling up of our support to ESPAD; the ongoing implementation of the new Regulation on new psychoactive substances (NPS).
Follow this news feed: EU